Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Bioorg Med Chem Lett ; 27(2): 314-318, 2017 01 15.
Article in English | MEDLINE | ID: mdl-27914800

ABSTRACT

Human kallikrein 1 (KLK1) is the most extensively studied member of this family and plays a major role in inflammation processes. From Ugi multicomponent reactions, isomannide-based peptidomimetic 10 and 13 where synthesized and showed low micromolar values of IC50 for KLK1 The most active compound (10) presented competitive mechanism, with three structural modifications important to interact with active site residues which corroborates its KLK1 inhibition. Finally, the most active compound also showed good ADMET profile, which indicates compound 10 as a potential hit in the search for new KLK1 inhibitors with low side effects.


Subject(s)
Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Drug Discovery , Enzyme Inhibitors/pharmacology , Kallikreins/antagonists & inhibitors , Peptidomimetics/pharmacology , Bridged Bicyclo Compounds, Heterocyclic/chemical synthesis , Bridged Bicyclo Compounds, Heterocyclic/chemistry , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Humans , Kallikreins/metabolism , Models, Molecular , Molecular Structure , Peptidomimetics/chemical synthesis , Peptidomimetics/chemistry , Structure-Activity Relationship
2.
Bioorg Med Chem Lett ; 26(5): 1485-9, 2016 Mar 01.
Article in English | MEDLINE | ID: mdl-26848109

ABSTRACT

The human tissue kallikreins (KLK1-KLK15) comprise a family of 15 serine peptidases detected in almost every tissue of the human body and that actively participate in many physiological and pathological events. Some kallikreins are involved in diseases for which no effective therapy is available, as for example, epithelial disorders, bacterial infections and in certain cancers metastatic processes. In recent years our group have made efforts to find inhibitors for all kallikreins, based on natural products and synthetic molecules, and all the inhibitors developed by our group presented a competitive mechanism of inhibition. Here we describe fukugetin, a natural product that presents a mixed-type mechanism of inhibition against KLK1 and KLK2. This type of inhibitor is gaining importance today, especially for the development of exosite-type inhibitors, which present potential to selectively inhibit the enzyme activity only against specific substrate.


Subject(s)
Biflavonoids/pharmacology , Biological Products/pharmacology , Serine Proteinase Inhibitors/pharmacology , Tissue Kallikreins/antagonists & inhibitors , Biflavonoids/chemistry , Biflavonoids/isolation & purification , Biological Products/chemistry , Biological Products/isolation & purification , Dose-Response Relationship, Drug , Garcinia/chemistry , Humans , Models, Molecular , Molecular Conformation , Serine Proteinase Inhibitors/chemistry , Serine Proteinase Inhibitors/isolation & purification , Structure-Activity Relationship , Tissue Kallikreins/metabolism
3.
Peptides ; 76: 80-6, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26775801

ABSTRACT

Tripeptidyl peptidase I (TPP-I), also named ceroid lipofuscinosis 2 protease (CLN2p), is a serine carboxyl lysosomal protease involved in neurodegenerative diseases, and has both tripeptidyl amino- and endo- peptidase activities under different pH conditions. We developed fluorescence resonance energy transfer (FRET) peptides using tryptophan (W) as the fluorophore to study TPP-I hydrolytic properties based on previous detailed substrate specificity study (Tian Y. et al., J. Biol. Chem. 2006, 281:6559-72). Tripeptidyl amino peptidase activity is enhanced by the presence of amino acids in the prime side and the peptide NH2-RWFFIQ-EDDnp is so far the best substrate described for TPP-I. The hydrolytic parameters of this peptide and its analogues indicated that the S4 subsite of TPP-I is occluded and there is an electrostatic interaction of the positively charged substrate N-terminus amino group and a negative locus in the region of the enzyme active site. KCl activated TPP-I in contrast to the inhibition by Ca(2+) and NaCl. Solvent kinetic isotope effects (SKIEs) show the importance of the free N-terminus amino group of the substrates, whose absence results in a more complex solvent-dependent enzyme: substrate interaction and catalytic process. Like pure TPP-I, rat spleen and kidney homogenates cleaved NH2-RWFFIQ-EDDnp only at F-F bond and is not inhibited by pepstatin, E-64, EDTA or PMSF. The selectivity of NH2-RWFFIQ-EDDnp to TPP-I was also demonstrated by the 400 times higher k(cat)/K(M) compared to generally used substrate, NH2-AAF-MCA and by its resistance to hydrolysis by cathepsin D that is present in high levels in kidneys.


Subject(s)
Aminopeptidases/chemistry , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/chemistry , Serine Proteases/chemistry , Amino Acid Sequence , Animals , Fluorescence Resonance Energy Transfer , Humans , Kinetics , Male , Proteolysis , Rats , Tissue Extracts/chemistry , Tripeptidyl-Peptidase 1
4.
Biochim Biophys Acta ; 1854(1): 73-83, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25448018

ABSTRACT

KLK7 substrate specificity was evaluated by families of fluorescence resonance energy transfer (FRET) peptides derived from Abz-KLFSSK-Q-EDDnp (Abz=ortho-aminobenzoic acid and Q-EDDnp=glutaminyl-N-[2,4-dinitrophenyl] ethylenediamine), by one bead-one peptide FRET peptide library in PEGA resin, and by the FRET peptide libraries Abz-GXX-Z-XX-Q-EDDnp (Z and X are fixed and random natural amino acids, respectively). KLK7 hydrolyzed preferentially F, Y or M, and its S1' and S2' subsites showed selectivity for hydrophilic amino acids, particularly R and K. This set of specificities was confirmed by the efficient kininogenase activity of KLK7 on Abz-MISLM(↓)KRPPGFSPF(↓)RSSRI-NH2 ((↓)indicates cleavage), hydrolysis of somatostatin and substance P and inhibition by kallistatin. The peptide Abz-NLY(↓)RVE-Q-EDDnp is the best synthetic substrate so far described for KLK7 [kcat/Km=455 (mMs)(-1)] that was designed from the KLK7 substrate specificity analysis. It is noteworthy that the NLYRVE sequence is present in human semaphorin 6B. KLK7 is activated by GAGs, inhibited by neutral salts, and activated by high concentration of kosmotropic salt. Pyroglutamic acid inhibited KLK7 (Ki=33mM) and is present in skin moisturizing factor (124mM). The KLK7 specificity described here and elsewhere reflects its participation in patho-physiological events in skin, the gastrointestinal tract and central nervous system, where KLK7 is significantly expressed.


Subject(s)
Glycosaminoglycans/pharmacology , Kallikreins/metabolism , Peptide Hydrolases/metabolism , Peptides/metabolism , Amino Acid Sequence , Binding Sites , Biocatalysis/drug effects , Fluorescence Resonance Energy Transfer , Humans , Hydrolysis/drug effects , Kinetics , Kininogens/metabolism , Molecular Sequence Data , Osmolar Concentration , Pyrrolidonecarboxylic Acid/pharmacology , Semaphorins/metabolism , Serpins/metabolism , Somatostatin/metabolism , Substance P/metabolism , Substrate Specificity , Time Factors
5.
ACS Med Chem Lett ; 5(2): 128-32, 2014 Feb 13.
Article in English | MEDLINE | ID: mdl-24900785

ABSTRACT

Human kallikrein 5 (KLK5) and 7 (KLK7) are potential targets for the treatment of skin inflammation and cancer. Previously, we identified isomannide derivatives as potent and competitive KLK7 inhibitors. The introduction of N-protected amino acids into the isomannide-based scaffold was studied. Some KLK5 inhibitors with submicromolar affinity (K i values of 0.3-0.7 µM) were identified, and they were 6- to 13-fold more potent than our previous hits. Enzyme kinetics studies and the determination of the mechanism of inhibition confirmed that the new isomannide-based derivatives are competitive inhibitors of both KLK5 and KLK7. Molecular docking and MD simulations of selected inhibitors into the KLK5 binding site provide insight into the molecular mechanism by which these compounds interact with the enzyme. The promising results obtained in this study open new prospects on the design and synthesis of highly specific KLK5 and KLK7 inhibitors.

6.
Bioorg Med Chem Lett ; 22(19): 6072-5, 2012 Oct 01.
Article in English | MEDLINE | ID: mdl-22959247

ABSTRACT

Human kallikrein 7 (KLK7) is a potential target for the treatment of skin inflammation and cancer. Despite its potential, few KLK7-specific small-molecule inhibitors have been reported in the literature. As an extension of our program to design serine protease inhibitors, here we describe the in vitro assays and the investigation of the binding mechanism by molecular dynamics simulation of a novel class of pseudo-peptide inhibitors derived from isomannide. Of the inhibitors tested, two inhibited KLK7 with K(i) values in the low micromolar range (9g=1.8µM; 9j=3.0µM). Eadie-Hofstee and Dixon plots were used to evaluate the competitive mechanism of inhibition for the molecules. Calculated binding free energies using molecular MM/PB(GB)SA approach are in good agreement with experimental results, suggesting that the inhibitors share the same binding mode, which is stabilized by hydrophobic interactions and by a conserved network of hydrogen bonds. The promising results obtained in this study make these compounds valid leads for further optimization studies aiming to improve the potency of this new class of kallikrein inhibitors.


Subject(s)
Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Enzyme Inhibitors/pharmacology , Kallikreins/antagonists & inhibitors , Bridged Bicyclo Compounds, Heterocyclic/chemistry , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Humans , Kallikreins/metabolism , Molecular Conformation , Structure-Activity Relationship
7.
Biochimie ; 93(10): 1701-9, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21689719

ABSTRACT

KLK13 is a kallikrein-related peptidase preferentially expressed in tonsils, esophagus, testis, salivary glands and cervix. We report the activation of KLK13 by kosmotropic salts and glycosaminoglycans and its substrate specificity by employing a series of five substrates derived from the fluorescence resonance energy transfer (FRET) peptide Abz-KLRSSKQ-EDDnp. KLK13 hydrolyzed all these peptides only at basic residues with highest efficiency for R; furthermore, the S(3) to S(2)' subsites accepted most of the natural amino acids with preference also for basic residues. Using a support-bound FRET peptide library eight peptide substrates were identified containing sequences of proteins found in testis and one with myelin basic protein sequence, each of which was well hydrolyzed by KLK13. Histatins are salivary peptides present in higher primates with broad antifungal and mucosal healing activities that are generated from the hydrolysis from large precursor peptides. KLK13 efficiently hydrolyzed synthetic histatin 3 exclusively at R(25) (DSHAKRHHGYKRKFHEKHHSHRGYR(25)↓SNYLYDN) that is the first cleavage observed inside the salivary gland. In conclusion, the observed hydrolytic activities of KLK13 and its co-localization with its activators, glycosaminoglycans in the salivary gland and high concentration of sodium citrate in male reproductive tissues, indicates that KLK13 may play a role in the defense of the upper digestive apparatus and in male reproductive organs.


Subject(s)
Glycosaminoglycans/pharmacology , Kallikreins/metabolism , Salts/pharmacology , Citrates/pharmacology , Enzyme Activation/drug effects , Female , Humans , Male , Salivary Glands/metabolism , Sodium Citrate , Substrate Specificity
8.
Biol Chem ; 392(6): 587-91, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21521074

ABSTRACT

The 3C proteinase, essential for human poliovirus (PV) replication, has unique characteristics as its three-dimensional structure resembles chymotrypsin, but its catalytic nucleophile is a cysteine SH group rather than the OH group of serine. Here, we describe the use of tellurium compounds as inhibitors of PV3C proteinase. A rapid, stoichiometric and covalent inactivation of PV3C was observed with both a chloro-telluroxetane and a bis-vinylic organotellurane. These compounds also inhibit human cathepsins B, L, S, and K with second order rate constants higher than those obtained for PV3C. Chloro-telluroxetane inhibits replication of PV in human embryonic rhabdomyosarcoma cells in the low micromolar range and below the toxic level for the host cells. Bis-vinylic organotellurane is more effective as antiviral agent but reduces the cell viability by 20% at 10 µm, a concentration almost completely inhibiting virus growth. This is the first description of inhibition of viral 3C proteinase with antiviral property by this class of compounds.


Subject(s)
Enzyme Inhibitors/pharmacology , Organometallic Compounds/pharmacology , Poliovirus/enzymology , Tellurium/chemistry , Viral Proteins/antagonists & inhibitors , 3C Viral Proteases , Cysteine Endopeptidases/metabolism , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Molecular Structure , Organometallic Compounds/chemistry , Structure-Activity Relationship , Viral Proteins/metabolism
9.
Biol Chem ; 391(9): 1105-12, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20635860

ABSTRACT

Here we report a detailed analysis of magnesium (Mg²+) ion effects on furin hydrolysis of fluorescent resonance energy transfer decapeptide substrates derived from canonical R-X-K/R-R furin cleavage motifs within certain viral envelope glycoproteins and eukaryotic proproteins. Using virus-derived sequences a selective activation of furin by Mg²+) ions was observed as a result of cooperativity between furin subsites. Furin hydrolysis of the peptides Abz-SRRHKR↓FAGV-Q-EDDnp (from measles virus fusion protein F0 and Abz-RERRRKKR↓GLFG-Q-EDDnp (from Asian avian influenza A, H5N1) was activated between 60- and 80-fold by MgCl2. It appears that virus envelope glycoprotein mutations have been selected to increase their susceptibility to furin within cells, a location where Mg²+ is present in adequate concentrations for activation. Both the pH profile of furin and its intrinsic fluorescence were modified by Mg²+ ions, which bind to furin with a K(d) value of 1.1 mM.


Subject(s)
Furin/metabolism , Magnesium/pharmacology , Viral Envelope Proteins/metabolism , Biocatalysis/drug effects , Enzyme Activation/drug effects , Fluorescence Resonance Energy Transfer , Humans , Hydrogen-Ion Concentration , Hydrolysis/drug effects , Influenza A Virus, H5N1 Subtype/chemistry , Influenza A Virus, H5N1 Subtype/genetics , Ions/chemistry , Ions/pharmacology , Magnesium/chemistry , Oligopeptides/chemistry , Proprotein Convertases/metabolism , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae Proteins/metabolism , Substrate Specificity , Viral Envelope Proteins/genetics
10.
J Biol Chem ; 285(28): 21437-45, 2010 Jul 09.
Article in English | MEDLINE | ID: mdl-20442413

ABSTRACT

Scytalidoglutamic peptidase (SGP) is the prototype of fungal glutamic peptidases that are characteristically pepstatin insensitive. These enzymes have a unique catalytic dyad comprised of Gln(53) and Glu(136) that activate a bound water molecule for nucleophilic attack on the carbonyl carbon atom of the scissile peptide bond. The hydrolysis by SGP at peptide bonds with proline in the P(1)' position is a rare event among peptidases that we investigated using the series of fluorescence resonance energy transfer peptides, Abz-KLXPSKQ-EDDnp, compared with the series Abz-KLXSSKQ-EDDnp. The preference observed in these two series for Phe and His over Leu, Ile, Val, Arg, and Lys, seems to be related to the structure of the S(1) subsite of SGP. These results and the pH profiles of SGP activity showed that its S(1) subsite can accommodate the benzyl group of Phe at pH 4 as well as the positively charged imidazolium group of His. In the pH range 2 to 7, SGP maintains its structure and activity, but at pH 8 or higher it is irreversibly denatured. The intrinsic fluorescence of the Trp residues of SGP were sensitive to the titration of carboxyl groups having low pK values; this can be attributed to the buried Asp(57) and/or Asp(43) as described in SGP three-dimensional structure. The solvent kinetic isotope effects and the proton inventory experiments support a mechanism for the glutamic peptidase SGP that involves the nucleophilic attack of the general base (Glu(136)) activated water, and establish a fundamental role of the S(1) subsite interactions in promoting catalysis.


Subject(s)
Fungi/enzymology , Glutamine/chemistry , Peptide Hydrolases/chemistry , Serine Endopeptidases/chemistry , Aspartic Acid/chemistry , Carbon/chemistry , Catalysis , Circular Dichroism , Histidine/chemistry , Hydrogen-Ion Concentration , Hydrolysis , Kinetics , Proline/chemistry , Protein Conformation , Tryptophan/chemistry
11.
Biochemistry ; 48(33): 7948-58, 2009 Aug 25.
Article in English | MEDLINE | ID: mdl-19580333

ABSTRACT

Foot-and-mouth disease virus, a global animal pathogen, possesses a single-stranded RNA genome that, on release into the infected cell, is immediately translated into a single polyprotein. This polyprotein product is cleaved during synthesis by proteinases contained within it into the mature viral proteins. The first cleavage is performed by the leader protease (Lb(pro)) between its own C-terminus and the N-terminus of VP4. Lb(pro) also specifically cleaves the two homologues of cellular eukaryotic initiation factor (eIF) 4G, preventing translation of capped mRNA. Viral protein synthesis is initiated internally and is thus unaffected. We used a panel of specifically designed FRET peptides to examine the effects of pH and ionic strength on Lb(pro) activity and investigate the size of the substrate binding site and substrate specificity. Compared to the class prototypes, papain and the cathepsins, Lb(pro) possesses several unusual characteristics, including a high sensitivity to salt and a very specific substrate binding site extending up to P(7). Indeed, almost all substitutions investigated were detrimental to Lb(pro) activity. Analysis of structural data showed that Lb(pro) binds residues P(1)-P(3) in an extended conformation, whereas residues P(4)-P(7) are bound in a short 3(10) helix. The specificity of Lb(pro) as revealed by the substituted peptides could be explained for all positions except P(5). Strikingly, Lb(pro) residues L178 and L143 contribute to the architecture of more than one substrate binding pocket. The diverse functions of these two Lb(pro) residues explain why Lb(pro) is one of the smallest, but simultaneously most specific, papain-like enzymes.


Subject(s)
Endopeptidases/chemistry , Endopeptidases/metabolism , Foot-and-Mouth Disease Virus/enzymology , Amino Acid Sequence , Binding Sites , Cysteine Endopeptidases/chemistry , Cysteine Endopeptidases/metabolism , Fluorescence Resonance Energy Transfer , Humans , Hydrolysis , Molecular Sequence Data , Papain/antagonists & inhibitors , Papain/chemistry , Papain/metabolism , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Substrate Specificity
12.
Arch Biochem Biophys ; 487(2): 105-14, 2009 Jul 15.
Article in English | MEDLINE | ID: mdl-19477160

ABSTRACT

We explored furin substrate requirements in addition to the motif R-X-K/R-R using synthetic fluorescent resonance energy transfer (FRET) decapeptides. These decapeptides were derived from furin cleavage sites in viral coat glycoproteins and human and bacterial protein precursors. The hydrolysis by furin of most substrate was activated by K(+) ion, whereas kosmotropic anions of the Hofmeister series were inhibitors. The analysis of furin hydrolytic activity showed that its efficiency is highly dependent on the particular combinations of amino acids at different substrate positions. There is a clear interdependence of furin subsites that must be taken in account in determining its specificity and also for the design of inhibitors. However, clear preferences were detected for substrates with S at P(1)', and V at P(2)', at P(3)' the amino acids D, S, L and A are almost equally frequent. In the non-prime subsites the best substrates presented S and H at P(6); basic amino acids at P(5); and no clear tendency at P(3). Interestingly, two amino acid substitutions on the prime side of the peptide derived from H5N1 influenza hemagglutinin furin processing site highly improved its hydrolysis. These modifications are possible by single point mutations, suggesting a potential yield of a more infectious virus.


Subject(s)
Furin/metabolism , Oligopeptides/chemistry , Oligopeptides/metabolism , Potassium Chloride/pharmacology , Amino Acid Sequence , Fluorescence Resonance Energy Transfer , Furin/chemistry , Humans , Hydrogen-Ion Concentration , Hydrolysis/drug effects , Kinetics , Molecular Sequence Data , Oligopeptides/chemical synthesis , Sodium Chloride/pharmacology , Substrate Specificity/drug effects
13.
Biochim Biophys Acta ; 1794(2): 367-73, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19056523

ABSTRACT

The secreted extracellular subtilase SR5-3 from Halobacillus sp. bacterium, isolated from the high-salt environment of Thai fish sauce, was utilized as a model halophilic serine protease. The dependence of salt activation on the size and structure of substrates was evaluated assaying the enzyme with Suc-AAPF-MCA and with the Fluorescence Resonance Energy Transfer (FRET) peptide Abz-AAPFSSKQ-EDDnp. Solvent isotope effects (SIE) and the thermodynamic parameters for activation of the hydrolysis of Suc-AAPF-MCA and Abz-AAPFSSKQ-EDDnp by SR5-3 protease in the presence of salts were also performed. All the obtained results support the notion that the salting out effect is responsible for the halophilic character of SR5-3, and the magnitude of its hydrolytic activity is mainly derived from the improvement of catalytic and/or interaction steps depending on the nature and size of the substrates, principally if they occupy the substrate prime subsites.


Subject(s)
Bacillaceae/enzymology , Bacterial Proteins/metabolism , Salts/pharmacology , Serine Endopeptidases/metabolism , Subtilisin/metabolism , Bacterial Proteins/chemistry , Catalysis , Enzyme Activation , Fluorescence Resonance Energy Transfer , Hydrogen-Ion Concentration , Hydrolysis , Kinetics , Salts/chemistry , Serine Endopeptidases/chemistry , Subtilisin/chemistry , Temperature
SELECTION OF CITATIONS
SEARCH DETAIL
...